Philips highlights data-driven integrated cardiology


August 26, 2022

Philips AI-powered smart interventional and diagnostic systems and home solutions connect care across the cardiac care journey to improve diagnostic confidence, increase efficiency and improve patient outcomes

Amsterdam, Netherlands and Barcelona, ​​Spain – Royal Philips (NYSE: PHG, AEX: PHIA), a global health technology leader, will showcase its latest integrated cardiology solutions at the European Society of Cardiology (ESC) Congress (August 26-29, Barcelona, ​​Spain). The company’s latest innovations in cardiology are helping to provide enhanced clinical information, enhance clinical confidence, increase critical care efficiency and improve cardiac care experiences, from diagnosis and treatment to home care.

The demands on cardiology departments have never been higher, pushing clinicians to balance the delivery of high-quality care for a growing number of complex patients with pressures to improve department efficiency. The Global Future Health Index Report 2022 commissioned by Philips shows that cardiology leaders not only view improvements in technology infrastructure as essential for managing and monitoring patients over long periods of time in out-of-hospital settings, but also essential for better diagnosing and treating demand increasing number of new patients.

“As health systems grapple with increasing demand for cardiology services and patient complexity, they face an ongoing challenge to deliver quality patient care while adapting to an increased focus on patient outcomes. results, efficacy and costs,” said Dr. Alexandra Goncalves, Chief Medical Officer, Precision Diagnostics at Philips. “Through our innovation in cardiology, Philips is uniquely positioned to provide definitive diagnostics and enable personalized patient management to improve cardiac care with greater efficiency, enhanced clinical insights and better experiences for patients and the staff. »

Powerful ecosystem for cardiovascular care
Philips software-defined systems deliver data-driven insights, backed by AI, to deliver the right care at the right time to help better manage even the most complex cardiology cases. End-to-end intelligent integrated technology streamlines communication between devices and systems to help identify and deliver clinical and operational improvements, build clinical confidence, enhance workflow efficiency, optimize resources and reduce the cost of care. Visitors to the Philips booth at ESC will see how the company is transforming cardiac care delivery into a connected future by integrating imaging, devices, software, IT and services, including:

  • Precision diagnostics for cardiology – Clinically intelligent diagnostic solutions, streamlined workflows, and actionable insights for data-driven cardiac care identify clear pathways for the most complex patient journeys. Advanced visualization solutions include Philips’ independent multi-modality image and information management workspace – Cardiovascular IntelliSpace – and its new echocardiography visualization, analysis and reporting workspace (Ultrasound workspace)a scalable solution making its European market debut at the ESC, which when paired with the Philips Ultrasound System (EPIQ CVx), leverages AI across a wide range of applications to provide advanced quantification and standardization with consistent on- and off-cart applications. Together these echocardiology workflow solutions help improve diagnostic confidence, improve outcomes and operational efficiency. Philips has also extended access to point-of-care hemodynamics for real-time blood flow assessment across its Lumify Portable Ultrasound. In addition, Philips will highlight its award-winning products Spectral CT 7500 for exceptional cardiac imaging for comprehensive cardiac assessment to help improve cardiac treatment pathways, and its portfolio of cardiac MRI solutions, including helium-free MR5300, Smart Workflow and powered by AI SmartSpeedalso making his debut in Europe at the ESC.
  • a bit intrusive treatment – Philips solutions for image-guided minimally invasive therapy help physicians decide, guide, treat and confirm the right care for each cardiac patient in real time. Built on Philips Image Guided Therapy System – Azurion – The company’s next-generation image-guided therapy platform, these solutions uniquely integrate best-in-class imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment for the most complex procedures. At ESC, Philips will demonstrate how its innovation EchoNavigator software allows users to EPIQ CVxi interventional cardiology ultrasound system to automatically fuse real-time 3D TEE (transesophageal echocardiography) with cardiac fluoroscopy X-ray imaging to monitor and support cardiac catheter operations. is also presented Coronary sequela fully integrated system for confident decision-making to improve cardiac catheterization laboratory performance during percutaneous coronary intervention (PCI) procedures, and hemodynamic workflow for continuous monitoring, seamless data flow and continuity for cath lab patients.
  • Ambulatory monitoring and diagnosis – Philips remote cardiac care solutions portfolio includes near real-time patient monitoring, telehealth, emergency and therapeutic care, as well as ambulatory cardiac diagnostic and monitoring solutions to deliver care with complete peace of mind confidence in post-acute settings for chronic disease and readmission management. Solutions, which help enable smooth transitions from hospital to home, include the Philips Extended Holter – ePatch up to 14 days of continuous high-quality ECG recording for reliable diagnosis [1]with robust data analysis provided by Philips cloud-based and AI-enabled Cardiologists Software. A recent Cardiologs study demonstrated how AI can quickly predict the onset of atrial fibrillation. Also featured at the ESC is Philips Questionnaire Managera cloud-based SaaS solution to better manage patient-reported outcomes, and Philips Head of care engagementhelping clinicians provide the right care at the right time, in the right place, while engaging cardiac patients to take a more active role in their recovery at home.

Cardiac Ultrasound Symposium hosted by Philips at ESC 2022
As cardiology leaders envision the future of heart failure diagnosis and treatment, Philips will host a Cardiac Ultrasound Satellite Symposium session at ESC – Echo in heart failure, what can we do better now? – Friday, August 26 at 3:30 p.m. CET, and streamed live for those not attending the ESC in person. The session will feature international thought leaders from the Netherlands, Italy and Spain who will share their views on the horizons of structural heart disease, the reality of using 3D for patients with of routine heart failure and their clinical experience with the fusion revolution. Visit Philips at ESC for more information.

Visit Philips Cardiology to learn how the company’s integrated systems, devices, computing, software and services help deliver fast, safe diagnosis and effective treatment to improve outcomes for patients with cardiovascular disease. Rejoin Philips at ESC (Hall 3, Booth #K155) to learn how its smart, data-driven, AI-powered systems and solutions help build clinical confidence, streamline cardiac imaging workflows, and improve the patient experience. cardiac care for patients and staff.

[1] The patient should replace the patch on day 5 of wearing, or sooner if necessary.

For more information, please contact:

Kathy O’Reilly
Philips Global Press Office
Such. : +1 978 221 8919
Email: [email protected]

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving the health and well-being of people and driving better outcomes in the across the health continuum – from healthy living and prevention to diagnosis, treatment and home care. Philips relies on cutting-edge technology and in-depth clinical and consumer insights to deliver integrated solutions. Based in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as consumer health and care. residence. Philips generated sales of €17.2 billion in 2021 and employs approximately 78,000 employees with sales and service in over 100 countries. Information about Philips can be found at

Source link


Comments are closed.